The Daily Papule

Meeting abstracts

AAD 2026

American Academy of Dermatology · Denver, 27–31 March 2026

1,877 abstracts, published in JAAD on 6 July 2026. Their text is on the JAAD website.

  1. 70667

    Ruxolitinib Cream Is Efficacious in Adults With Moderate Atopic Dermatitis Regardless of Baseline Disease Severity and Previous Medication History

    Pinto PH, Asadullah K, … senior author Gooderham MJ

  2. 70840

    Lebrikizumab provides meaningful improvements of absolute endpoints in patients with moderate-to-severe atopic dermatitis in a real-world-setting: interim analysis of the non-interventional study AD-LIFE

    Lauffer F, Gutzmer R, … senior author Thaçi D

  3. 70870

    Predictors of Sustained Response After Dose Reduction in Moderate-to-Severe Atopic Dermatitis: A Systematic Review

    Burla MM, de Oliveira Rosa L, … senior author Haber R

  4. 70910

    Medicaid Coverage as a Barrier to Biologic Access for Atopic Dermatitis: A Cross-Sectional Analysis of State Level Variability

    Hemelt S, Fong J, … senior author Culotta N

  5. 71084

    Psychometric Validation of The Caregiver and Child Atopic Dermatitis Control Tools: A Preliminary Analysis

    Gillespie J, Fang M, … senior author Simpson E

  6. 71340

    Prurigo nodularis and atopic dermatitis feature increased cutaneous expression of MRGPRX3

    Marani M, Rajeh A, … senior author Kwatra S

  7. 71368

    Unmet needs in atopic dermatitis (AD) treated with current biologic therapies: results from an international cross-sectional cohort study

    Chovatiya R, Dillon P, … senior author Irvine AD

  8. 71499

    Updating the American Academy of Dermatology Clinical Practice Guidelines for Systemic Treatment of Moderate to Severe Atopic Dermatitis in Adults

    Frazer-Green L

  9. 72087

    Moisturizer and Prevention of Atopic Dermatitis in Pediatric Population: A Meta-Analysis

    Nguyen N, Le Duc Thien H, … senior author Bao NT

  10. 72213

    Sustained Health-Related Quality of Life and work productivity improvements with Delgocitinib 20 mg/g Cream in Chronic Hand Eczema - Results from the Phase 3 Open-Label Extension DELTA 3 Trial

    Armstrong A, Gold LS, … senior author Agner T

  11. 72372

    National-, State-, and County-Level Prevalence of Diagnosed Atopic Dermatitis in the United States

    Abuabara K, Capozza K, … senior author Brookhart MA

  12. 72487

    Improvement in Body Regions and Clinical Signs of Atopic Dermatitis with APG777: Results from the Phase 2 APEX Part A Study

    Silverberg JI, Blauvelt A, … senior author Guttman-Yassky E

  13. 72537

    Lebrikizumab from Skin to Airways: Comorbid Allergic Rhinitis in Patients with Atopic Dermatitis and the PREPARED-1 Perennial Allergic Rhinitis Trial Design

    Golant A, Casale T, … senior author Corren J

  14. 72585

    Current and emerging treatments for pediatric chronic hand eczema: A structured review

    Yeung K, Lowe M, Molin S

  15. 72740

    Real-World Effectiveness of Upadacitinib for Atopic Dermatitis Across Body Regions by Prior Biologic Exposure in the AD-VISE Study

    Gooderham M, Lang C, … senior author Ameen A

  16. 72824

    Delgocitinib cream 20 mg/g for moderate to severe Chronic Hand Eczema: outcomes over 16 weeks by prior systemic therapy exposure

    Bissonnette R, Schliemann S, … senior author Kircik L

  17. 72893

    Efficacy and Safety of Tapinarof Cream 1% Once Daily Monotherapy in Adults and Children with Atopic Dermatitis: Pooled Results from ADORING 1 and 2

    Silverberg JI, Eichenfield LF, … senior author Bissonnette R

  18. 72928

    Behavioral Characteristics and Parent-Child Concordance in BASC-3 Reports Among Children with Atopic Dermatitis: A Single-Center Cross-Sectional Study

    Ma S, Kartawira K, … senior author Wan J

  19. 72962

    Topical PDE4 Inhibition with Crisaborole Alters Skin Microbiome Composition in Atopic Dermatitis

    Bearss J, Greene R, … senior author Mesinkovska N

  20. 72967

    Real-world Effectiveness and Unmet Need among Adult Patients with Atopic Dermatitis on Advanced Systemic Therapy: Results from the Adelphi Real World Disease Specific Programme in US and Europe

    Sohn A, Deininger KM, … senior author Silverberg JI

  21. 72986

    A Novel Multidisciplinary Dermatological Care Model for Managing Patients with Acne and Atopic Dermatitis: Consensus Guidance for Pharmacists

    Sihota A, Abouzant A, … senior author Sauder M

  22. 73148

    The DELTA TEEN Phase 3 trial: systemic exposure and safety profile of delgocitinib cream in adolescents with moderate to severe Chronic Hand Eczema

    Molin S, Baselga E, … senior author Rubel D

  23. 73227

    Online CME Improved Dermatologists’ Preparedness to Incorporate New Topical Nonsteroidal Treatments for Atopic Dermatitis into Practice

    Dermer S, Betz B, Hanley K

  24. 73422

    Assessing the Clinical Defensibility of Oral JAK Inhibitors for Short-Term Use in Moderate-to-Severe Atopic Dermatitis

    Pirrone S, Martin K

  25. 73449

    Clinical Characteristics of Atopic Dermatitis in the Elderly

    Rechdan M, Arthur A, … senior author Montanez-Wiscovich M

  26. 73475

    Dupilumab Improves Anxiety and Depression in Adult Patients With Atopic Dermatitis or Prurigo Nodularis

    Ständer S, Bieber T, … senior author Rossi AB

  27. 73553

    Machine Learning–Based Identification of Moderate-to-Severe Atopic Dermatitis in US Patients Using the TARGET-DERM Atopic Dermatitis Registry

    Cordey M, Behera B, … senior author Simpson E

  28. 73555

    Real-World Characteristics and Burden of Patients Initiating Advanced Systemic Therapy in the TARGET-DERM Atopic Dermatitis Registry

    Silverberg JI, Faller RW, … senior author Abuabara K

  29. 73560

    Patient and caregiver preferences for atopic dermatitis prescription treatments: side effects vs. rapid relief

    Loiselle AR, Johnson JK, Begolka WS

  30. 73585

    International Eczema Council Atopic Dermatitis Low Disease Activity and Remission Consensus Definitions: Results of a Global Modified Delphi Initiative

    Merola J, Bartley B, … senior author Irvine A

  31. 73591

    Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% Provides Improvements in Caregiver-Reported Outcomes That are Maintained Long Term: Results for Patients Aged 2–5 years With Mild-to-Moderate Atopic Dermatitis in the INTEGUMENT-OLE Trial

    Eichenfield L, Boguniewicz M, … senior author Simpson E

  32. 73614

    Comparative Efficacy of Targeted Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: an updated network meta-analysis

    Ji S

  33. 73642

    Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis: Subgroup Analysis of Patients With Involvement of the Face and/or Scalp in the STRATUM Trial

    Ferris LK, Cook-Bolden FE, … senior author Gooderham MJ

  34. 73652

    Atopic Dermatitis Skin Microbiota Changes in Diverse Ethnically Patients Following Prebiotic Skincare Regimen

    Dumbuya H, Bouslimani A, … senior author Draelos ZD

  35. 73662

    Evaluating the Safety of a Novel Polypodium Leucotomos Gummy Supplement in Pediatric Atopic Dermatitis

    Hakim C, Galaria A, Hussain A

  36. 73832

    Pediatric atopic dermatitis and socioeconomic status in Olmsted County: a case-control study

    Ge A, Tollefson M

  37. 73841

    Efficacy and Safety of Lebrikizumab is Maintained up to 4 Years in Patients With Moderate-to-Severe Atopic Dermatitis: first year of ADlong Long-Term Extension Trial

    Weidinger S, Irvine A, … senior author Reich K

  38. 73858

    Novel Regulatory T-cell enhancing Biologic Rezpegaldesleukin: Phase 2b Efficacy, Safety, and Baseline Severity–Dependent Treatment Response in Moderate-to-Severe Atopic Dermatitis

    Chaudhry S, Silverberg J, … senior author Zalevsky J

  39. 73884

    Systematic Review of the Impact of Omega-3 Supplementation on Atopic Dermatitis Diagnoses in Pregnant Mother-Infant Pairings

    Ling L, Ni H, Billero V

  40. 73906

    Upadacitinib Leads in Efficacy: Bayesian Network Meta-Analysis of Four JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis

    Babul A, Mehta D, … senior author Babul N

  41. 73947

    Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in Adults

    Okereke R, Baghoomian W, … senior author Simpson E

  42. 74100

    Efficacy and Safety of Abrocitinib in Patients With Atopic Dermatitis Who Have Skin of Color: A Post Hoc Analysis of JADE EXTEND

    Alexis A, Herranz P, … senior author Watkins M

  43. 74285

    Ocular Adverse Events of Biologic Therapies Targeting the IL-4/IL-13 Pathway in Atopic Dermatitis: A Systematic Review and Meta-analysis

    Alves de Paiva F, Marcolini Elias MC, … senior author Paysano ML

  44. 74315

    Preclinical development of an anti-IL-22 antibody for the treatment of atopic dermatitis

    Pfeiffer K, Gibbons M, … senior author Sullivan T

  45. 74392

    Omega-3 Supplementation and Risk of Eczematous Dermatitis in Patients Receiving Isotretinoin: Findings From a Prospective Cohort Study

    Olds H, El Othmani A, … senior author Moossavi M

  46. 74453

    Risk factors for dupilumab associated ocular surface disease (DAOSD) in atopic dermatitis patients: a systematic review and meta-analysis

    Barros de Deus Nunes Junior E, Rosa Li SW, … senior author Hopkins Z

  47. 74458

    Real-World Utilization of Upadacitinib in Atopic Dermatitis and Achievement of Minimal Disease Activity: 6-Month Interim Analysis of the Multicenter Large Cohort Study P24-965 in China

    Jin H, Chen L, … senior author Sun Y

  48. 74514

    Sustained Improvement in Signs and Symptoms of Atopic Dermatitis in Adolescents and Adults Initiating Dupilumab in Real-World Practice: 5-Year Completer Interim Analysis From the PROSE Registry

    Lima HC, Fonacier L, … senior author Bosman K

  49. 74515

    Dupilumab Improves Patient-Reported Symptom Control Among Adults With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: 6-Year Follow-up Results From the RELIEVE-AD Study

    Wang Z, Yang M, … senior author Kimball A

  50. 74520

    Clinical and Humanistic Burden of Skin Pain Amongst Adult Patients with a History of Moderate-to-Severe Atopic Dermatitis Receiving an Advanced Systemic Therapy: Results from the Adelphi Real World Disease Specific Programme in US and Europe

    Sohn A, Deininger KM, … senior author Silverberg JI